在帕金森病中逐渐的铁沉积和广泛的神经功能障碍:多模式MRI研究
Shuo Liu1, Xinhui Wang2, Wei Wei2
1Department of Medical Imaging, Xinxiang Medical University & Henan Provincial People's Hospital, Zhengzhou, China.
Quantitative imaging in medicine and surgery
|March 12, 2026
概括
帕金森病显示大脑铁的增加和功能连接的改变,随着疾病的发展阶段而恶化. 多模式MRI可以跟踪这些变化,帮助诊断和治疗开发.
科学领域:
- 神经成像是一种神经成像.
- 神经退行性疾病 神经退行性疾病
- 生物标志物发现发现
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,其阶段依赖机制尚不完全理解.
- 多模式磁共振成像 (MRI) 提供了一种非侵入性方法来研究PD中的功能和结构性大脑变化.
- 了解这些变化对于开发有效的诊断和治疗策略至关重要.
研究的目的:
- 在帕金森病中使用多式核磁共振 (MRI) 来表征依赖阶段的功能和与铁相关的大脑变化.
- 探索这些大脑变化和PD患者的运动严重程度之间的关联.
- 调查MRI指标作为PD诊断和分期生物标志物的潜力.
主要方法:
- 纳入了104名PD患者 (早期和晚期) 和53名健康对照.
- 定量敏感性测绘 (QSM) 测量了黑色物质 (SN) 和白色球体 (GP) 中的铁沉积量.
- 静止状态fMRI (rs-fMRI) 使用区域同质性 (ReHo) 和低频波动的分数振幅 (fALFF) 来评估功能变化.
主要成果:
- 患有PD的患者在NS和GP中呈现铁沉积增加,晚期水平更高.
- 铁沉积与运动严重程度正相关 (UPDRS-III分数).
- 早期的PD显示了视觉区域的功能变化;晚期的PD显示了运动,前端双关节和边缘回路的广泛变化,与运动和认知功能有关.
结论:
- 多种模式的MRI揭示了PD的特定阶段的病理生理变化,包括渐进的铁沉积和网络功能障碍.
- 整合ReHo,fALFF和QSM为PD的特征提供了一个框架.
- 这些成像指标显示了早期诊断,疾病分期和帕金森病治疗发展的生物标志物的潜力.
更多相关视频
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
11.4K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.4K
相关概念视频
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Disorders of the Nervous Tissue
3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
